MLTX - MoonLake Immunotherapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

MLTX is currently covered by 10 analysts with an average price target of $32.72. This is a potential upside of $20.1 (159.27%) from yesterday's end of day stock price of $12.62.

MoonLake Immunotherapeutics's activity chart (see below) currently has 122 price targets and 135 ratings on display. The stock rating distribution of MLTX is 75% BUY, 20.83% HOLD and 4.17% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 29.16% with an average time for these price targets to be met of 100.89 days.

Highest price target for MLTX is $70, Lowest price target is $10, average price target is $32.72.

Most recent stock forecast was given by ANDREAS ARGYRIDES from OPPENHEIMER. First documented stock forecast 21-Jul-2022.

Best performing analysts who are covering MLTX - MoonLake Immunotherapeutics:

Andreas Argyrides Raghuram Selvaraju Kelly Shi Brian Abrahams Prakhar Agrawal Leon Wang

Currently out of the existing stock ratings of MLTX, 18 are a BUY (75%), 5 are a HOLD (20.83%), 1 are a SELL (4.17%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 21-Nov-2025

$50

$39.2 (362.96%)

$50

1 months 5 days ago
(05-Oct-2026)

8/39 (20.51%)

$38.62 (339.37%)

86

Buy Since 18-Jul-2023

$29

$18.2 (168.52%)

4 months 9 days ago
(01-Jul-2026)

1/2 (50%)

$9.87 (51.59%)

173

Buy Since 09-Feb-2026

$30

$19.2 (177.78%)

$30

5 months 1 days ago
(09-Jun-2026)

1/9 (11.11%)

$12.2 (68.54%)

109

Buy Since 31-Aug-2023

$30

$19.2 (177.78%)

$25

5 months 29 days ago
(12-May-2026)

1/16 (6.25%)

$11.81 (64.93%)

265

Show more analysts

Please expand the browser size to see the chart

What is MLTX (MoonLake Immunotherapeutics) average time for price targets to be met?

On average it took 101 days for the stock forecasts to be reached, with an average price target met ratio of 29.16%.

Which analyst most recently updated their price target on MLTX (MoonLake Immunotherapeutics)?

Andreas Argyrides

Which analyst has the most public recommendations on MLTX (MoonLake Immunotherapeutics)?

Andreas Argyrides works at CHARDAN CAPITAL and has 7 price targets and 4 ratings on MLTX

Which analyst is the currently most bullish on MLTX (MoonLake Immunotherapeutics)?

Kaveri Pohlman with the highest potential upside of $59.2

Which analyst is the currently most reserved on MLTX (MoonLake Immunotherapeutics)?

Samantha Semenkow with the lowest potential downside of -$14.9
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?